New drugs are not enough: addressing social determinants as a critical component of drug-resistant TB care
The global fight against drug-resistant TB (DR-TB) is hindered by an underappreciation of the importance of the social determinants of TB. Although shorter, all-oral regimens have improved treatment options, high rates of non-adherence persist due to stigma, financial hardship and other healthcare a...
Saved in:
| Main Authors: | D. Giovenco, N.S. Shah, K. Ansorge, D. Operario, N.R. Gandhi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Union Against Tuberculosis and Lung Disease (The Union)
2025-04-01
|
| Series: | IJTLD Open |
| Subjects: | |
| Online Access: | https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2025/00000002/00000004/art00001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of heteroresistance on treatment outcomes of people with drug-resistant TB
by: R. Crowder, et al.
Published: (2024-10-01) -
Progress in programmatic management of drug-resistant TB, WHO Eastern Mediterranean Region, 2018-2023
by: K. Bennani, et al.
Published: (2024-09-01) -
15-year trends in efficacy and effectiveness of treatment outcomes in drug-resistant pulmonary TB
by: M.J. Nasiri, et al.
Published: (2025-04-01) -
STUDY OF ADVERSE DRUG REACTIONS OF LINEZOLID IN DRUG RESISTANT TUBERCULOSIS PATIENTS
by: Rinto Susilo, et al.
Published: (2025-06-01) -
Predicting Treatment Outcomes in Patients with Drug-Resistant Tuberculosis and Human Immunodeficiency Virus Coinfection, Using Supervised Machine Learning Algorithm
by: Mojisola Clara Hosu, et al.
Published: (2024-10-01)